FDA Announces Key Actions to Advance Development of Novel Coronavirus Medical Countermeasures

January 27, 2020 FDA

FDA Announces Key Actions to Advance Development of Novel Coronavirus Medical Countermeasures

Previous Article
FDA Continues Strong Support of Innovation in Development of Gene Therapy Products
FDA Continues Strong Support of Innovation in Development of Gene Therapy Products

FDA Continues Strong Support of Innovation in Development of Gene Therapy Products

Next Article
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer

FDA granted accelerated approval to Tazverik (tazemetostat) for the treatment of adults and pediatric patie...